Introduction
During the last 20 years, the presence of several pharmaceutically active compounds (PhACs) in water bodies has garnered increasing attention and worldwide concern. The effluents from wastewater treatment plants (WWTPs) are the main sources of PhACs in aquatic environments (Daughton and Ruhoy, 2009 ). In fact, most WWTPs are designed to comply with conventional pollutant thresholds such as those for nutrients, organic matter and solids, but they are not efficient at completely eliminating organic compounds at low concentrations ranging from ng/L to μg/L (Verlicchi et al., 2012) . Advanced tertiary treatments are required to improve the quality of WWTP effluents discharged into sensitive receiving water bodies and those utilized for potable reuse, industrial reuse and irrigation purposes . Among the advanced tertiary treatments, adsorption onto granular activated carbon (GAC) has been proven to be a viable technique to remove PhACs (Boehler et al., 2012; Hu et al., 2016a; Mailler et al., 2016a) . The main drawbacks of GAC applications are (i) the need to properly treat and dispose of both the spent carbon and the sludge generated during the filtration process, and (ii) the need to remove the effluent organic matter before filtration. The effluent organic matter significantly diminishes the adsorption capacity of GAC and thus the operating lifetime. An alternative may be to take advantage of the organic matter retained in the GAC filter to support the growth of autochthonous biomass attached to the GAC particles. This colonization implies the development of biological activity inside the filter bed, and the process can thus be defined as biological activated carbon (BAC) filtration. BAC filters, compared to other biofiltration systems, have the advantage of presenting a high adsorption capacity, which contributes to the removal of PhACs as well as to biofilm development. It has been demonstrated that the GAC structure with its roughness and high porosity, possesses characteristics that promote microbial growth, thus providing better support compared to other materials such as sand, clay and anthracite (Luo et al., 2014) . With regard to the abatement of PhACs, BAC filters combine biodegradation with physical adsorption (Zhang et al., 2010) . By combining these two mechanisms, a wider range of PhACs can be addressed, thus increasing the potential of such technology for application as a tertiary treatment (Kalkan et al., 2011; Velten et al., 2011) . Justo et al. (2015) showed that during BAC filtration treatment of reverse osmosis brine, approximately 60% of the pharmaceutical content was depleted by the biological treatment. When applied after coagulation and clarification of surface water for drinking purposes, this technique was confirmed to be a sustainable treatment process for PhACs, with removals higher than 75% . In this context, the biofiltration process is often evaluated as a part of larger treatment trains in which BAC filters represent only one step of the entire treatment line, according to the multiple barrier criteria. Few studies have documented situations in which BAC filters, applied as part of wastewater reuse schemes to treat wastewater for reclamation purposes, were proven to effectively remove many PhACs (Rattier et al., 2012; Reungoat et al., 2012) . Rattier et al. (2012) suggested that biodegradation can enhance the removal of the compounds that are less adsorbed onto GAC. Similarly, BAC filters have also been applied as the last step of an experimental indirect potable reuse treatment train comprising UF and ozone (Gerrity et al., 2011) . When preceded by UF and ozone, BAC filtration effectively decreased the concentration of PhACs in the treated WWTP effluent to below the method detection limit (MDL) . Nevertheless, to the best of our knowledge, little is known regarding the application of BAC filters as a stand-alone tertiary treatment for the removal of PhACs. Paredes et al. (2016) conducted a comparative study of BAC and sand biofiltration, which were both applied as stand-alone tertiary treatments. However, this study was conducted at lab-scale with synthetic water and spiked concentrations of PhACs. Rather than investigating the real operating conditions, the authors mainly focused on the specific removal mechanisms. Understanding the mechanisms shed light on the contributions of the biological processes taking place in these biofiltration systems. To assess whether biodegradation allows for greater removal of PhACs by BAC filters rather than by conventional GAC treatment, gaining insights into the mechanisms involved is key in biofiltration studies. As far as we know, only Rattier et al. (2012) and Paredes et al. (2016) have distinguished between biodegradation and adsorption during the BAC filtration of wastewater. Studying the BAC filtration of real treated wastewater at pilot scale, Gerrity et al. (2011) found higher concentrations of both total coliform and fecal coliform after BAC passage. Since bacteria grow on GAC particles, they can be detached and washed out from the biofilter. Aiming to prevent this escape, an ultrafiltration (UF) step can be performed after the BAC filter. When this BAC-UF combination was applied as a tertiary treatment, total coliforms, E. coli, Enterococci and Somatic coliphages were almost completely removed due to the UF step (Weemaes et al., 2011) . On the other hand, single UF is ineffective for the removal of most of the PhACs found in secondary effluents of WWTPs. Several studies have shown limited removal of PhACs by UF membrane alone (Sheng et al., 2016; Snyder et al., 2007) . Ultrafiltration alone is ineffective for PhACs removal because of its high molecular weight cut off and the unavoidable disadvantage of fouling when it is applied to wastewater treatment (Secondes et al., 2014) . Weemaes et al. (2011) tested the use of this system for removal of PhACs from secondary effluents in short-term experiments. This concept, applied at the laboratory scale, was able to almost completely remove antibiotics, iodinated contrast media and analgesic anti-inflammatory compounds. Hence, to gain useful information for a real application of this BAC-UF technology, further investigations need to verify this hypothesis at a larger scale. Moreover, the long-term performance of the system after reaching PhACs breakthrough must also be investigated.
In summary, only a limited number of studies have used BAC filters as advanced technology to remove PhACs from secondary effluents. Furthermore, in these few studies, BAC filters were usually preceded by other treatment units (i.e., the technology was applied to refine tertiary effluents). When this was not the case, the studies were conducted at the laboratory scale and, therefore, within a controlled environment. Moreover, a long-term investigation of the BAC-UF performance, including the start-up phase, a few months of steady operation, and the GAC breakthrough, was not performed in any of the previous studies. To the best of our knowledge, this is the first time that a BAC filter has been evaluated as a stand-alone advanced treatment for the removal of PhACs at pilot scale during one year of operation; the results of this study will provide additional information about the extent to which biological processes can enhance the overall abatement of PhACs. Our hypothesis is that BAC, applied as a stand-alone tertiary treatment, can achieve better performance than other biofiltration systems and guarantee higher short-term levels of PhACs abatement than the conventional GAC treatment while providing the same long-term achievements.
The objective of the current work was to evaluate the long-term performance of the BAC-UF process in treating secondary effluents with environmentally relevant concentrations of PhACs at pilot scale. A labscale study with more controlled conditions was also performed to gain insights into the respective roles of biodegradation and adsorption.
Materials and methods

BAC-UF pilot plant
The BAC-UF pilot plant setup coupled two separate units, as shown in Fig. 1 . The pilot plant was fed by secondary effluent (the wastewater characteristics are reported in Table S1 ) from a municipal WWTP designed for biological nutrient removal. The BAC filter was filled with ORGANOSORB ® 10-CO coconut shell-based GAC (Table S2) to an operating volume of 2 m 3 . This resulted in an empty bed contact time (EBCT) of 50 min. The BAC bed, operated in downstream mode, was maintained submerged by a control valve placed at the outlet of the filter. The backwash of the BAC bed filter was controlled on-line when reaching a head loss threshold in the filter. The secondary effluent was pumped into the fixed bed BAC filter in a downstream configuration with a flow rate of 48 m 3 /day. The BAC filter operating conditions are reported in Table S3 . Taking into account this influent flow, one day of operation corresponded to 38.3 bed volumes (BV [m 3 water /m 3 GAC ]) of wastewater treated by the pilot plant. Considering that this system was operated and monitored for one year, at the end of the experimental period, 13,800 BV were filtered through the BAC filter bed.
The BAC outlet fed the ultrafiltration (UF) tank. The ultrafiltration membrane was placed after the BAC in order to minimize the amount of BAC particles that leached into the finished water, and at the same time to avoid microbial breakthrough. The UF operating conditions are shown in Table S4 . The UF tank water, known as concentrate, was recirculated on top of the BAC filter with a flow rate of 60 m 3 /day ( Fig. 1 ). Continuous oxygenation of the BAC unit through recycling of the concentrate was provided while the UF membrane was operated in a 10/10 s mode with scouring coarse bubbles.
The pilot plant was equipped with pressure and oxygen probes, as well as flow meters arranged in several spots ( Fig. 1 ) to monitor and control the biological performance of the BAC filter bed and ensure the standard functioning of the entire system.
Lab-scale set-up
The lab-scale setup consisted of 2 transparent PVC columns (L = 42 cm, D = 5.5 cm) filled with the same GAC used in the pilot plant. Column C1 was kept biologically active, and both adsorption and biodegradation occurred. Column C2 was biologically inactivated by continuously adding sodium azide (NaN 3 ) to a final concentration of 250 mg/L, with the goal of inhibiting any biological activity (Paredes et al., 2016) ; thus limiting the PhACs removal mechanisms to only adsorption. NaN 3 was applied from day zero until the last day of operation. The columns were operated from top to bottom at room temperature in the dark (to prevent algae growth and PhACs photolysis). The influent flow was set to achieve an EBCT value of 50 min, the same as that in the BAC pilot plant.
No automatic backwashing operation of the columns was performed. To prevent clogging phenomena, the secondary effluent was filtered through a 200 μm nylon filter prior to column filtration. After the 200 μm nylon filter, the wastewater was directly pumped through the columns by a peristaltic pump (Watson Marlow, The Netherlands). Then, in order to reduce pressure build up, the columns were manually backwashed monthly. The backwash procedure was applied with water and air simultaneously, with a duration of 30 s. This is the time necessary to reach the overflow opening. This lab-scale setup was operated for four months.
Experimental plan
The BAC-UF pilot plant was operated continuously for one year, covering the start-up, steady operation, and GAC breakthrough, thereby allowing for a well-developed active biofilm. During this period, the experimental plan consisted of (i) measuring the concentrations of PhACs in the influent and effluent of the BAC-UF pilot plant to calculate the removal efficiencies after different time intervals, (ii) assessing the biological activity of the biomass attached to GAC particles and inside the BAC filter bed, and (iii) evaluating the textural properties of the GAC particles as indicators of their adsorption capacity. Table 1 summarizes the primary studied parameters with the related sampling strategies. The BAC-UF pilot plant was equipped with two sampling machines from which 24 h composite samples were withdrawn during each sampling campaign. During the sampling campaigns, both the EBCT and the hydraulic retention times were considered. These two samplers were positioned as depicted in Fig. 1 . The first machine sampled the influent (SPI-P: Fig. 1 ), while the second machine sampled the effluent from the UF tank (SPE-P: Fig. 1 ). Additionally, in the lab-scale setup, grab samples were taken at different time intervals during each sampling event, and composite samples were manually prepared. From both the pilot plant and the columns, samples were taken monthly, and all underwent the same treatment. Briefly, amber glass bottles pre-rinsed with methanol and MilliQ water were used to take samples from both installations. The samples were pre-filtered with 0.45 μm filters, and a fraction of the volume was used for conventional pollutant analysis, while the remaining volume was stored at −25°C until the solid phase extraction (SPE) procedure for the analysis of PhACs was performed.
Pharmaceutically active compounds (PhACs)
A total of thirteen PhACs were chosen to assess the removal capacity of the BAC-UF pilot plant. The compounds were selected according to the following criteria, which were fulfilled by the selected PhACs: (a) they were found at relevant concentrations in the secondary effluent used to feed the pilot plant, (b) they were reported to have low or very low removals during conventional activated sludge processes (Verlicchi et al., 2012) , (c) they belong to different therapeutic groups and, hence have different physical-chemical properties that should result in different removal behavior, (d) they belong to both the EU Priority and Watch List (European Commission, 2015) and finally, when possible, (e) they have not been studied before in BAC filtration units. This selection resulted in the following list composed of (i) five antibiotics: sulfamethoxazole (SMX), azithromycin (AZIT), ofloxacin (OFLX), trimethoprim (TRIM) and ciprofloxacin (CIPX); (ii) three beta-blockers: metoprolol (MTP), atenolol (ATN) and propanolol (PROP); (iii) two psychiatric drugs: carbamazepine (CBZ) and venlafaxine (VNLX); and (iv) three additional PhACs belonging to other therapeutic groups, i.e., hydrochlorothiazide (HDCT), irbesartan (IRB) and bezafibrate (BZF).
Analytical method
These thirteen PhACs were analyzed following the analytical procedure developed by Gros et al. (2012) . Briefly, wastewater samples were first filtered through 1 μm glass fiber filters followed by 0.45 μm nylon membrane filters (Whatman, U.K.), and then a suitable volume of 0.1 M Na 2 EDTA solution, was added to achieve a final concentration of 0.1% (g solute / g solution). Moreover, the water samples were spiked with an appropriate volume of a standard mixture containing surrogate standards to reach a concentration of 100 ng/L in each wastewater sample. Afterwards, the water samples were extracted using Oasis HLB cartridges (60 mg, 3 mL). The cartridges were conditioned with 5 mL of methanol followed by 5 mL of HPLC-grade water at a flow rate of 2 mL/min. A total of 100 mL of wastewater was loaded onto the cartridges at a flow rate of 2 mL/min. After the samples were preconcentrated, the cartridges were rinsed with 6 mL of HPLC grade water and air dried to remove the excess water. Finally, analytes were eluted with 6 mL of pure methanol at a flow rate of 1 mL/min. The extracts were evaporated to dryness under a gentle nitrogen stream and reconstituted with 1 mL of methanol/water (10:90, v/v). Finally, 10 μL of a 1 ng/μL standard mixture containing all isotopically labeled standards was added to the extract to provide internal standards. Chromatographic separation was carried out with an ultra-performance liquid chromatography (UPLC) system (Waters Corp. Mildford, MA, USA) using an Acquity HSS T3 column (50 mm × 2.1 mm i.d., 1.7 μm particle size) for the compounds analyzed under positive electrospray ionization (PI) and an Acquity BEH C18 column (50 mm × 2.1 mm i.d., 1.7 μm particle size) for the compounds analyzed under negative electrospray ionization (NI), both from the Waters Corporation. The UPLC instrument was coupled with a 5500QqLit, triple quadrupole-linear ion trap mass spectrometer (5500 QTRAP, Applied Biosystems, Foster City, CA, USA) with a Turbo V ion spray source. Two multiple reaction monitoring (MRM) transitions per compound were recorded by using the Scheduled MRM™ algorithm, and the data were acquired and processed using Analyst 2.1 software.
Biological activity
With the objective of monitoring the biological activity of the biomass attached to the GAC particles and inside the BAC filter bed, the following measurements were carried out.
Biomass quantification
After 5750 BV (five months) of operation of the BAC-UF pilot plant, the biomass attached to the GAC particles was quantified by an adenosine triphosphate (ATP) measurement. To conduct these measurements, GAC samples were treated according to the protocol described by Velten et al. (2007) . In short, the GAC particles were rinsed three times in phosphate buffer. Then, 200 mg (wet weight) of sample was transferred to an Eppendorf tube together with 100 mL sterile phosphate buffer and 300 mL BacTiterGlo TM (Promega Corporation, Madison, WI, USA), and the resulting luminescence was measured as relative light units (RLU). The results were converted to ATP concentrations using a calibration curve.
Respirometric assays
Together with biomass quantification, the same GAC samples taken after 5750 BV for ATP measurements (2.6.2) were also used in a series of respirometric batch experiments aiming at determining biomass activity. In this set of experiments, the specific heterotrophic activity (SHA), which is the maximum organic matter uptake rate per gram of biomass (g COD * g −1 SS * d −1 ), and specific nitrifying activity (SNA), which is the maximum ammonia uptake per gram of biomass (g NH 4 + * g −1 SS * d −1 ), were determined by means of the following respirometric method: i) the biomass was harvested from the GAC samples; ii) 1 L glass bottles containing 10 mL of biomass were saturated with oxygen; iii) aeration was interrupted; iv) a non-limiting concentration of substrate was added (200 mg COD * L −1 and 20 mg NH 4 + * L −1 ); v) the decrease in the DO concentration was monitored and vi) the COD and NH 4 + concentrations after 1, 3 and 6 h of reaction were measured (Paredes et al., 2016) .
Textural properties
To gain insights into the status of the GAC particles throughout the operational period of the pilot plant, the porosity of the particles inside the filter was measured. The specific surface area (calculated with the Brunauer, Emmet and Teller method, i.e., the BET surface), micropore area and volume were determined on the basis of the adsorption isotherms of nitrogen (ISO [International Organization for Standardization], 2010). These measurements were realized at Quantachrome GmbH & Co. KG laboratory in Odelzhausen (Germany). First, the samples were pretreated at 80°C for 3 h under vacuum. Subsequent analysis was performed on a Quantachrome Quadrasorb with nitrogen at 77 K. The micropore area and micropore volume were calculated with the "t-Plot-method".
Results and discussion
This section presents the results corresponding to the long-term monitoring of the biological activity assessment (Section 3.1) and removal of PhACs (Section 3.2). Since the understanding of the respective roles of adsorption and biodegradation is key for the design of the BAC The position of the sampling points is shown in Fig. 1. filtration units, the distinction between these two mechanisms is addressed in Section 3.3.
BAC-UF pilot plant: biological activity assessment
A screening of the removal of conventional pollutants was performed throughout the experimental cycle to monitor the performances of the pilot plant. The total organic carbon (TOC) removal of 11.9% has to be mostly attributed to GAC adsorption. However this mean value is lower than typical TOC removal values obtained with GAC filters applied as tertiary treatment. The low removal range may depend on the specific characteristics of the residual TOC. Li et al. (2005) found that when the ratio between the biodegradable fraction of TOC (BTOC) and TOC was below certain values (0.2-0.3), only 14% TOC removal was achieved by BAC filtration of WWTP secondary effluent. On the other hand, although only partially, this could also be related to the carbon particle size. GAC with bigger particle size, as the ones used in the current work (Table S2 ), would exhibit more pore blockage and thus lower organic matter removal (Meinel et al., 2016) . Accordingly, when GAC particles with features similar to the ones used in the current work were implemented in BAC filters, the mean TOC removal ranged between 11.6 and 15.7% (Li et al., 2006; Lin et al., 2010) . The consumption of dissolved oxygen (DO) together with the nitrification and removal of COD that took place throughout the BAC filter (Table 2) suggested the presence of biological activity on the GAC particles in the filter bed. Furthermore, ATP measurements, which have been proven to be a suitable parameter for the quantification of active biomass in GAC filters (Magic-Knezev and van der Kooij, 2004), were performed to confirm these results ( Table 3 ). The amount of ATP in the analyzed samples is between 6E−04 and 10E−04 [g ATP / g GAC]. These values are in line with the ATP concentrations measured in 30 different GAC filters at nine treatment plants with biological activity in the Netherlands (Magic-Knezev and van der Kooij, 2004) . Additional evidence of the biological activity of the biomass attached to the GAC particles was provided by the heterotrophic and nitrifying activity measurements. These values provide further information on the activity of the microorganisms developed inside the BAC filter bed (Paredes et al., 2016) .
Long-term performance of BAC-UF pilot plant: PhACs
In the following section, the long-term performance of the BAC-UF pilot plant is reported in terms of the removal of PhACs. Two distinct phases (phase 1, P1, and phase 2, P2) can be clearly distinguished by the two different PhACs removal efficiencies during the operational period of the pilot plant (Fig. 2) . The P1 phase spanned the first eight months of operation from January 2016 to September 2016 and corresponded to 9200 (BV) of treated wastewater. The second phase started in October 2016 and ended in January 2017. During this cycle, 4600 additional BV were treated by the BAC-UF pilot plant. The whole experimental period resulted in a final value of 13,800 treated BV, after one year of operation. During P1, an average removal of 82% was achieved, while this value dropped consistently to an average of 38% during P2. For the duration of P1, markedly lower concentrations of antibiotics, beta-blockers and psychiatric drugs were observed in the effluent. In fact, the compounds belonging to these therapeutic groups were very well removed, reaching average removal values of 78, 89 and 83%, respectively (Fig. 2) . Additionally, for the three remaining compounds representative of the other therapeutic groups, the mean removal throughout P1 was also high (79% on average). The reported values of the micropore volume, area and BET surface of the carbon particles measured during this first experimental cycle (Table 3) were close to the values of the fresh material. Hence, the GAC particles were characterized by a high adsorption capacity, which may contribute to the high abatement level. A total of 44 pilot and full-scale studies with GAC were reviewed by Benstoem et al. (2017) , who reported that an average PhACs removal of 80% was reached for BV values in the range of 800-20,000; however, for most studies, such high removals occurred at BV values b10,000. On the other hand, in the GAC sample taken after 11 months of operation (Table 3) , the GAC properties had decayed. This phenomenon seems in line with the decay of the adsorption performances of the BAC-UF pilot plant during P2, resembling a breakthrough curve. The breakthrough of PhACs in BAC and GAC filters is regulated by several factors (i.e., the adsorbability of the substance itself, the background matrix, the adsorbent, the temperature, and the filtration parameters), which differ for each compound (Snyder et al., 2007; Knopp et al., 2016) . Therefore, each compound may display a different breakthrough curve. Nevertheless, P2 was characterized by an overall significant drop in the removal efficiency. Table 4 summarizes the studies that are considered state-of-the-art references, together with the related operational conditions applied. These references are compared with our results. For the removal of compounds not previously studied with BAC filtration, our results are compared with removals obtained by the pilot and full-scale GAC filtration units.
Antibiotics
The removal of trimethoprim, a bacteriostatic agent commonly found in secondary effluents of WWTPs, was over 90%. This antibiotic had the highest removal efficiency calculated in this study. Nonetheless, the compound is hydrophilic (log K ow is 0.91). Additionally, at pH 7, this molecule is almost completely neutral. These features should suggest a low affinity for GAC adsorption, but in spite of that, this compound showed good adsorption onto GAC (Kårelid et al., 2017; Yang et al., 2011) . Therefore, when BAC filters were applied as advanced treatments to remove PhACs from synthetic wastewater, and in drinking water treatment plants (DWTPs), 95% of trimethoprim was removed Paredes et al., 2016; Reungoat et al., 2011) . Notably, a BAC filter operated with an EBCT of 10 min was able to reach only 55% trimethoprim removal (Weemaes et al., 2011) , thus suggesting that the EBCT is crucial for the removal of certain PhACs with BAC filtration. The fluoroquinolone antibiotics ciprofloxacin and ofloxacin displayed 86% and 77% removal during the first 9200 BV. Ciprofloxacin is relatively hydrophilic (log K ow b 1.7); thus, it should not be highly adsorbed onto GAC. The BAC filter bed is continuously loaded with effluent organic matter that supports biofilm growth, and the biofilm is usually negatively charged. In contrast, ciprofloxacin has a positive charge at pH values of approximately 7.
Therefore, the electrostatic interactions taking place between the molecules and the biofilm surface significantly enhanced the removal of this compound in the BAC-UF pilot plant. In all likelihood, the 86% removal should be attributed to the cooperation of adsorption with other mechanisms. The structure of ofloxacin includes halogens (Cl or F), ketone functions and aromatic rings, which are known to enhance adsorption on activated carbon (De Ridder et al., 2011) . Similar results were reported by Mailler et al. (2016a) , although these authors applied a filter filled with micro-GAC and powdered activated carbon (PAC) at pilot scale. However, there is a lack of studies on the BAC removal of these two fluoroquinolone antibiotics. Therefore, these results supply useful information on this topic. Sulfamethoxazole and azithromycin were the compounds with the lowest adsorbability during P1. This trend also continued during P2. The average removal calculated throughout the experimental period was 51% for both antibiotics, while during P1, the removals were 73% and 63% for sulfamethoxazole and azithromycin, respectively. Although their distinct pKa and log D values (pka = 1.6 and 8.75; log D = 0.89 and 4.02 for sulfamethoxazole and azithromycin respectively) would suggest different behaviors, they exhibited similar removals. Azithromycin belongs to the macrolide group of antibiotics. Macrolides are characterized by relatively high log D values and by a positive charge state at pH 7 (Le-Minh et al., 2010) . According to these features, a good adsorption capacity is expected. However, azithromycin exhibited only moderate removal (63%) during the first 9200 BV of operation. Macrolides exhibited 80-95% removal in DWTPs that utilized PAC with a contact time of 4 h in river water with an initial DOC concentration of 3.5 mg/L (Westerhoff et al., 2005) . Nevertheless, no studies with GAC and/or BAC were found with regard to azithromycin removal from WWTP effluents. In addition, since this antibiotic is one of the few PhACs included in the watch list of substances for European Union-wide monitoring (Decision 2015 /495/EU of 20 March 2015 (European Commission, 2015 ), the current work provides relevant information concerning applicable tertiary treatment for the abatement of this watch-list-substance. In contrast, the low removal of sulfamethoxazole is clearly ascribable to its negative charge at pH =7-8, which causes electrostatic repulsion with the negatively charged activated carbon surface. Moreover, due to the low log D value of 0.89, sulfamethoxazole prefers to remain in the water phase instead of being adsorbed. In other BAC filtration studies, this sulfonamide antibiotic was highly removed (90%) (Jiang et al., 2017) . However, two main features differentiate the current work from the reported studies with higher sulfamethoxazole removals: the quality of the source water feeding the BAC, as well as the number of BV. With regard to the number of BV, no information is available in those studies. On the other hand, the pretreatment applied before feeding the BAC may explain the better performance obtained for sulfamethoxazole removal. In fact increasing the pretreatment before BAC results in lower concentrations of both dissolved organic matter (DOM) and particulate organic matter (POM). Less DOM entails less competition with PhACs, while less POM results in less pore blockage with consequential easier access for organic micropollutants (Ersan et al., 2016) . In keeping with these statements, only 12% sulfamethoxazole removal was obtained when the BAC filters were fed with reverse osmosis brine (Justo et al., 2015) , even though this concentrated water was pretreated with an advanced oxidation process (Table 4 ). The highest removal efficiency found in other biofiltration studies for sulfamethoxazole was 60% (Müller et al., 2017) . However, this 60% removal was achieved after 2160 BV passed throughout the filter, and with filter operations resulting in an EBCT of 33 h, which is forty times higher than the EBCT used in the current work.
Beta-blockers
The three beta-blockers, metoprolol, atenolol and propanolol, were highly removed during the 9200 BV phase, with mean values of 90, 93 and 83%, respectively. The specific adsorption capacity on GAC for metoprolol and atenolol suggested that these compounds have high affinities for this porous material (Kårelid et al., 2017) . Furthermore, the positive charge of these compounds at the pH of the wastewater enhanced their electrostatic attraction to the GAC surface as well as to the organic matter adsorbed onto it. Hence, although they are resistant to biodegradation, high removals can be achieved due to their tendency to be adsorbed onto GAC. Therefore, in studies conducted with BAC filters, removal efficiencies similar to the values achieved by the BAC-UF pilot plant in the current study were obtained Paredes et al., 2016) . Considerably lower removals were obtained when filtering materials other than GAC were applied in sequential biofiltration of wastewater (Müller et al., 2017) , and when 10 mg/L PAC were added (Sheng et al., 2016) . No studies on the interaction of propanolol and BAC filters, have been found.
Psychiatric drug
The psychiatric drug carbamazepine was highly removed during the 9200 BV phase, with an average value of 86%, whereas venlafaxine displayed 79% removal. The positive charge of these compounds at the pH of the wastewater enhanced the electrostatic attraction to the GAC surface and the organic matter adsorbed onto it. Hence, although they are resistant to biodegradation, due to their tendency to be adsorbed onto GAC, high removal efficiencies were also obtained when applying BAC filters at the laboratory scale (Paredes et al., 2016) . However, to achieve higher removal values (90-95%) with BAC filtration, energy and cost-intensive pretreatments would be required (Reungoat et al., 2011) . For these two compounds, no removal was observed during a 639-day study with biologically activated anthracite and sand filters operating as a stand-alone tertiary treatment (Müller et al., 2017) .
Other therapeutic groups
The diuretic drug hydrochlorothiazide was one of the compounds that were removed to a great extent, showing 93% mean removal during the first phase. Hydrochlorothiazide is hydrophilic and almost neutral at pH 7; hence, according, to these features it should not be removed very well via AC adsorption. Thus, when PAC was applied in a lab-scale filter bed to remove PhACs from the secondary effluent, a 20% breakthrough for hydrochlorothiazide was reached after 10 h of operation (Hu et al., 2016b) . Hydrochlorothiazide has been reported to be resistant to biodegradation in both sand and anthracite filters (Rattier et al., 2014; Bertelkamp et al., 2014) , while up to 70% of it was removed in batch experiments with BAC (Rattier et al., 2012) . These differences may suggest that this compound exhibits a major affinity for the biomass the develops on GAC rather than other support material. This high affinity may explain the 93% removal, which has never been reported before in previous studies on the biofiltration of secondary effluent. The antihypertensive drug irbesartan was steadily removed throughout P1 yielding an average value of 79%. Irbesartan is negatively charged, and therefore, no electrostatic attraction with the GAC surface should occur. In this regard, the charge of PhACs is more relevant to the adsorption process than the hydrophobic interactions. However, hydrophobic interactions are expected to be more significant for negatively charged solutes than for neutral or positively charged solutes (De Ridder et al., 2011) . Thus, due to the high hydrophobicity of irbesartan (log K ow = 5.31), interactions with the GAC surface and adsorption mechanisms are promoted. Similar achievements were obtained with two GAC pilot-scale columns in series applied to treat secondary effluents (Kårelid et al., 2017) .The authors that performed this study observed a breakthrough for irbesartan that was earlier than the value reported in the present study. In our case, an approximately 20% breakthrough is reached after 9200 BV, while in the mentioned study, a 90% breakthrough is reached after 5000 BV of treated wastewater. One explanation of the dissimilarity between the results presented above and other similar studies with activated carbon is the biomass presence and activity characterizing the BAC system. The discrepancy between the values obtained in the current work and those predicted based on both substance-related properties and lab-scale studies highlight two aspects that should be taken into account. First, for some compounds, the physical-chemical properties are not perfectly suited to explain the behavior during the AC processes. Second, applying technology in real conditions entails some aspects that do not occur in more controlled environments. One compound with physical-chemical properties that correctly predict the adsorptive behavior is the cholesterollowering drug bezafibrate. For this compound, a 67% concentration reduction was achieved. This molecule is negatively charged and also has a log D value of −0.11, thus making it highly hydrophilic. These properties may explain the reason why bezafibrate was the compound with the lowest removal value. However, the removal obtained in the current work (67%) is higher than the results achieved with a large scale micro GAC fluidized bed operating as a tertiary treatment, in which this compound was moderately removed (bezafibrate = 53-55%) (Mailler et al., 2016b) . Similar behavior was also observed in a BAC filter followed by a UF step in preliminary short-term studies, where 52% of bezafibrate was removed (Weemaes et al., 2011) .
Contributions of adsorption and biodegradation processes
In this section, the contributions of adsorption and biodegradation processes for the removal of PhACs in the BAC filter are addressed. This comparison has been done by comparing two lab-scale systems, one biotic (with biologically active biomass, C1) and the one abiotic (C2). The difference between the removal efficiencies of the two systems (C1 and C2) can be used as a measure of the contribution of the biomass to the overall abatement of the PhACs. In the functioning of the biotic column (C1), we were able to identify two distinct phases with regard to biomass establishment inside the column and its role in the removal of PhACs. The first phase (from day 1 to day 40) was before the colonization occurred, while the second phase (days 40 to 120) was after biomass colonized the filter bed. In terms of bed volumes, the first phase was from 0 to 1440 BV, while the second one covered the last eighty days of operation, resulting in a total of 4320 BV. In the biotic column C1, the removal for some compounds was higher in the second phase than before colonization (Table 5 ). This lag was due to the time required for the biofilm to grow and establish a well-developed structure. Since the study was started with fresh GAC particles, it took almost two months of operation for the biofilm to actively begin participating in the removal process. A similar lag-phase lasting 60 days was observed by Maeng et al. (2011) . Furthermore, when studying the functional diversity of the microbial community in BAC filters, Xiang et al. (2013) noticed that a relatively stable steady state was reached by day 40.
By analyzing the removal mechanisms, we found three different classes of behavior: (a) compounds with very high removal due to only adsorption onto GAC, (b) compounds with very high removal mostly due to adsorption onto GAC with a slight contribution by the biofilm and (c) compounds with high removal due to adsorption with a very significant contribution by the biofilm.
(a) Very high removal due to only adsorption
This group comprises the PhACs for which the concentrations decreased below their quantification limits (LOQ and LOD are reported in Table S5 ) in both C1 and C2. Metoprolol, atenolol, trimethoprim and propranolol were indeed completely removed in every sampling event. Since there was no biological activity in C2 and since photolysis was prevented (the columns were covered with aluminum foil), evaporation can be considered negligible (Carballa et al., 2004) , and biosorption was shown to be insignificant (Bertelkamp et al., 2014) ; thus, adsorption onto GAC is the only process in charge of the abatement of PhACs. With regard to C1, although biodegradation can occur, the extent to which it occurs could not be detected due to the predominant role of adsorption. As a confirmation of their affinity for GAC, these four PhACs reported high removal efficiencies (N75%) in several GAC pilot plant studies (Kårelid et al., 2017; Altmann et al., 2016; Beijer et al., 2017) , but those efficiencies were still lower than the removal efficiencies obtained in the present study.
(b) Very high removal mostly due to adsorption The removal of hydrochlorothiazide, venlafaxine, carbamazepine and irbesartan increased slightly with the transition from pre-and post-colonization, and these compounds were highly removed (N83%) by the biologically active filter. For this group, a small difference between C1 and C2 was found. This difference may suggest that the biomass contributed to the overall removal. After the biofilm developed after 40 days, the total removal was improved by 4% for hydrochlorothiazide, 7% for venlafaxine and carbamazepine, and 14% for irbesartan. Biodegradation alone, when operating as the sole removal process, is not efficient in abating the two psychiatric drugs encountered in the current work (Dolar et al., 2012) . These compounds have been reported as recalcitrant to biodegradation in several biofiltration studies (Carpenter and Helbling, 2017) . No studies were found regarding the biodegradation of hydrochlorothiazide or irbesartan in biologically active filters, but the diuretic and antihypertensive drugs were found to be unaffected by either full-scale MBR treatment (Kim et al., 2014) , or by conventional activated sludge systems (Joss et al., 2006) . In the current work, although these compounds were adequately removed by the BAC column, we observed a small difference between the two different columns. Consequently, adsorption has to be considered as the main mechanism involved.
(c) High removal due to adsorption and biodegradation
The remaining five PhACs were positively affected by the growth and development of biomass inside C1. The altered conditions inside column C1 contributed to an increase in the removal efficiency. The removals in C1 were higher than the removals achieved in C2. The effect of biological activity on the overall removal resulted in a 36% improvement for the most affected PhACs (azithromycin) and a 22% improvement for the least affected compound (ciprofloxacin). The improvements for ofloxacin, sulfamethoxazole and bezafibrate produced by the biofilm contribution to the overall removal were 25, 30 and 32%, respectively. To the best of our knowledge, there is a lack of information on the role played by biodegradation in biofilters for all these substances, but sulfamethoxazole showed a recalcitrant behavior with respect to biodegradation in several biofiltration studies (Carpenter and Helbling, 2017) . Nevertheless, Table 5 indicates that the 30% improvement in sulfamethoxazole removal was the result of the removal increasing from 53% in C2 to 75% in C1. Ciprofloxacin, ofloxacin and azithromycin have been reported to be poorly biodegradable during conventional wastewater treatment (Dolar et al., 2012; Ternes et al., 2016) . However, the conditions present inside a BAC filter -operating as an attached growth reactor-can be significantly different from a conventional activated sludge reactor; thus, different removal efficiencies can be achieved (Luo et al., 2014) . Unlike most of the studied PhACs, the 32% improvement obtained for bezafibrate may be explained by its relatively high biodegradability (Falås et al., 2016) . As supported by the findings related to group (c), the use of GAC as filtering material may result in higher biological activity compared to the less porous support for biomass growth. Globally, for nine out of the thirteen compounds studied in the lab-scale setup, it was possible to identify the added value of having biomass throughout the biofilter, i.e., the role of biodegradation.
Role of biofilm in the BAC-UF pilot plant
The lab-scale BAC filtration experiments revealed the role played by biodegradation in the overall PhACs removal process. Although this contribution is different for each compound, this work help to provide a further explanation of the processes taking place in the long-term study carried out with the pilot-scale BAC-UF. In this regard, note that during the second phase of the pilot plant operation (P2, after the fall related to surpassing 9200 BV), and more precisely after the drop observed from day 240 onwards, two different trends in terms of the removal of PhACs were identified. For the first group of compounds (group a), the removal efficiency continued to decrease throughout the remaining time. This group included the substances for which physical adsorption onto GAC particles was the main removal mechanism. This decreasing trend is confirmed by the GAC sample analyzed for textural property measurements during P2 (Table 3 , Month 11). The results reveal decreases in all the parameters used to represent the adsorption capacity (micropore volume and BET surface). These results reflect the saturation of the GAC particles and, therefore, explain the removal efficiency drop that was observed for the compounds belonging to group (a). In group (a), since there are no further mechanisms involved in the removal, beyond adsorption, an increase in the saturation level results in a decrease in the removal capacity. Metoprolol was selected as a representative of this group (Fig. 3.a) . On the other hand, the second observed trend was exhibited by compounds that displayed an additional removal capacity after the fall related to 9200 BV. The extra removal capacities shown by some compounds may be the result of biodegradation phenomena taking place within the BAC filter. This trend was associated with compounds whose removals were positively affected by biofilm development inside the biotic column during the lab-scale experiments (group c). Azithromycin was chosen as a representative compound and is depicted in Fig. 3.b . From the trend of azithromycin, we can see that the removal efficiency decreased between 9200 and 11,500 BV, but then remained stable from 11,500 BV until the end of the monitoring period. Since this compound was characterized by a positive biofilm contribution in the lab-scale column experiment (Table 5) , we hypothesize that biodegradation is the mechanism that allows for the additional abatement of PhACs when GAC filter beds reach high BV values; i.e., at long operating times.
As long as GAC particles maintained their adsorption capacities, lower influent concentrations should result in either higher or constant removal by adsorption onto GAC. However, when the carbon particles became saturated, the removal efficiencies over a given time span decreased, despite the stable influent concentrations (Fig. 3.b ). However, after the drop (beginning of the dotted arrow), the removal efficiency was stabilized at value of approximately 25%. This stabilization is likely attributable to biodegradation processes. Nevertheless, the stabilization of the removal of azithromycin after 11,500 BV, which is considered to be due to biological degradation, is based only on three measurements. The presence of biomass partially compensates for the diminished GAC adsorption capacity.
Conclusions
The results of the presented work provide the following conclusions:
• The current work shows how a BAC-UF pilot plant can be operated over the long term as a stand-alone tertiary treatment. With regard to PhACs abatement in WWTP effluents, the implementation of this technology allowed for 78, 89, 83 and 79% removal of antibiotics, beta-blockers, psychiatric drugs and a mix of other therapeutic groups, respectively. • The long-term evaluation highlighted how these high levels of removal are time dependent. The high removal levels were reached and maintained during the first 9200 BV of operation. Subsequently, however, the performance of the system diminished due to the saturation of the adsorption capacity. Therefore, actions should be taken to ensure a consistent abatement level. • Azithromycin, a commonly used antibiotic included in the EU Watch List of emerging contaminants, and five other PhACs have been studied for the first time in BAC filtration systems. During BAC filtration of secondary effluent, removals of 63, 67, 77, 79, 83 and 86% were obtained for azithromycin, bezafibrate, ofloxacin, irbesartan, propranolol and ciprofloxacin, respectively. • Adsorption onto GAC was proven to be the main mechanism in the removal of PhACs in BAC filters. Nevertheless, the biological activity characterizing the BAC filter contributed to higher removal efficiencies for five compounds in the BAC filter than in the conventional abiotic GAC filter. The removal improvements were 22, 25, 30, 32 and 35% for ciprofloxacin, bezafibrate, ofloxacin, azithromycin and sulfamethoxazole, respectively. 
